Skip to content

Utility of BioGlue® surgical adhesive in preventing air leaks in lung volume reduction surgery (LVRS)

A controlled trial comparing stapling with BioGlue® surgical adhesive versus stapling with buttressed bovine pericardium in lung volume reduction surgery (LVRS)

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN07886743
Enrollment
25
Registered
2009-07-24
Start date
2005-09-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery for emphysema Respiratory Emphysema

Interventions

Patients are randomised via sealed randomised envolopes opened on the day of surgery. Patients are then randomised to LVRS with two different adjuncts to staple line: 1. BioGlue® 2. Pericardial buttre

Sponsors

Heart of England NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients undergoing LVRS 2. Forced expiratory volume in one second (FEV1) less than 40% 3. FEV1/forced vital capacity (FVC) ratio less than 50% following challenges with beta 2 agonists/ipratropium bromide and a trial of oral corticosteroids 4. Residual volume of greater than 140% 5. Severe emphysema with heterogeneity ("target areas") documented on high resolution computed tomography (CT) scans 6. Less than 75 years of age, but greater than 18 years of age, either sex 7. Clinically stable for 1 month before entry to the study

Exclusion criteria

Exclusion criteria: 1. Patients who do not consent to the trial 2. Patients with known hypersensitivity to albumin, bovine products, or glutaraldehyde 3. Patients who have been treated with an investigational product and have not completed the entire follow-up period for that investigational product 4. Patients who are unwilling or unable to complete all study evaluations

Design outcomes

Primary

MeasureTime frame
To demonstrate an increase in the frequency of an air leak free post-operative hospital course for patients receiving BioGlue® as a pneumostatic sealant as compared to patients receiving the pericardial buttressed stapling. Post-operatively, occurrence of air leaks will be assessed on a per patient basis, twice daily.

Secondary

MeasureTime frame
1. Incidence of re-operation due to air leaks 2. Volume of fluid loss in chest tube drain 3. Time to air leak cessation 4. Incidence of complications/adverse events 5. Early (hospital discharge) mortality and late mortality (through final follow-up) Measured twice daily.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026